According to the information center of national elites foundation,the
industrial production of the national spray medication for treatment of
migraine with the brand name of “Migraine Cut” is officially announced in the
world with the support of the Pardis technology park.

In this ceremony, Reza Ramezani, CEO
of the MimDarou Knowledge-based Company, expressed: 67.11% of people of Iran have
migraine, which is almost nine and a half of the population of Iran. The rate
of disease in the world is 12% and about 800 million people.

CEO of the company that produces this
medication affirmed: to date, 200 thousand of this drug has been produced and
distributed in 130 drug store in less than a month. Currently, the pharmacies
of Tehran, Isfahan, Rasht and Qom have this medication, and we hope that all
provinces of the country have this medication until the next six months.

What Is Migraine Cut?

Migraine Cut is a medication produced
after 25 years of Iranian and international studies and contains an integrated
essence of medicinal herbs based on traditional medicine resources. This
medication is in the form of nose spray. Since the majority of patients with
migraine experience gastric problems, especially nausea and vomiting, this
medication is the best option to use in acute phase (migraine attack) of the
disease. During the clinical trial stage, this medication was tested on more
than three thousand patients, 96% of whom reported significant changes in the
treatment process. In addition, about 81% of patients with migraine who used
the migraine cut reported stopped headache.